Gilead Taps Sanofi’s Berger as Chief Medical Officer (1)

(Adds analyst comment starting in the fourth bullet.)

Gilead hired Sanofi’s Dietmar Berger to serve as chief medical officer, succeeding Merdad Parsey.

• The appointment of Berger is effective January 2
• He most recently served as the chief medical officer at Sanofi
• RBC analyst Brian Abrahams writes that Berger is a hemotologist/oncologist by training
  • “Gilead may be seeking to leverage his expertise in heme/onc development to double down on their oncology pipeline,” the analyst said
  • The appointment also suggests that Gilead may continue to expand its its immunology and inflammation portfolio
• In July, Gilead said Parsey would leave the ...